News
Verywell Health on MSN16h
Lilly’s Oral GLP-1 Drug Shows Modest Weight Loss Results Compared to Injectables
People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...
A string of blunders led to the value of Novo Nordisk plummeting last week. Could a new weight-loss pill help it regain its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback